As for GLP-1 RAs, there was not any significant results obtained in our study when compared with placebo and other anti-diabetes which was supported by the results of a cohort study [49], two meta-analysis [50, 51] and a case-control study using Danish Health Service data [52]. The gene discussed is GCG; the disease is diabetes mellitus.